I really don't agree with this notion that a study with only 12 participants will never be of much value because the sample size is too small. Statistical analysis is about more than just sample size. One needs to take into account the standard deviation of the population data and the extent to which the results from our sample deviate from the population mean.
The statistic that matters is the less than 1 in 1,000 chance of all participants surviving the trial on a placebo.
It's a pretty compelling statistic. Hard to see how the FDA would not consider that enough to justify the designation.
With respect to funding, I think the new board would be silly to make any decisions prior to hearing back on the ODD application - especially given how soon it is expected.
If the board could announce the successful ODD designation and at the same time give a positive update on the progress of patients on the extension trial, we'd be in a very good position to get all the funds we need on quite reasonable terms.
- Forums
- ASX - By Stock
- PAA
- The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1371
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $86.77M |
Open | High | Low | Value | Volume |
19.5¢ | 19.8¢ | 19.5¢ | $67.86K | 346.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 360690 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 792103 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 360690 | 0.195 |
17 | 617084 | 0.190 |
22 | 966649 | 0.185 |
21 | 1067238 | 0.180 |
6 | 421143 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 792103 | 8 |
0.210 | 99629 | 4 |
0.215 | 244632 | 6 |
0.220 | 109118 | 1 |
0.225 | 65040 | 2 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online